{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T08:11:08Z","timestamp":1778227868984,"version":"3.51.4"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,3]],"date-time":"2027-02-03T00:00:00Z","timestamp":1801612800000},"content-version":"am","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000124","name":"National Institutes of Health Office of Research on Women's Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000124","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jtha.2025.11.008","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T07:41:45Z","timestamp":1765266105000},"page":"387-398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anticoagulation stewardship from menstruation to menopause: a toolkit for clinical management"],"prefix":"10.1016","volume":"24","author":[{"given":"Divyaswathi","family":"Citla-Sridhar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shruti","family":"Karanth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Van Beek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara","family":"Lech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9981-8990","authenticated-orcid":false,"given":"Bethany","family":"Samuelson Bannow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.11.008_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arcmed.2022.11.016","article-title":"Impact of hospital-based multidisciplinary anticoagulation stewardship programs","volume":"54","author":"Porres-Aguilar","year":"2023","journal-title":"Arch Med Res"},{"key":"10.1016\/j.jtha.2025.11.008_bib2","doi-asserted-by":"crossref","first-page":"953","DOI":"10.4081\/cp.2017.953","article-title":"Reducing error in anticoagulant dosing via multidisciplinary team rounding at point of care","volume":"7","author":"Sharma","year":"2017","journal-title":"Clin Pract"},{"key":"10.1016\/j.jtha.2025.11.008_bib3","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S1473-3099(16)00065-7","article-title":"Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis","volume":"16","author":"Schuts","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jtha.2025.11.008_bib4","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jtha.2024.11.024","article-title":"Safe and effective anticoagulation use: case studies in anticoagulation stewardship","volume":"23","author":"May","year":"2025","journal-title":"J Thromb Haemost"},{"issue":"11","key":"10.1016\/j.jtha.2025.11.008_bib5","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1007\/s11606-022-07528-y","article-title":"Special Considerations for Women of Reproductive Age on Anticoagulation","volume":"37","author":"Azenkot","year":"2022","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jtha.2025.11.008_bib6","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1097\/01.AOG.0000446826.46833.c0","article-title":"ACOG Committee Opinion no. 598: Committee on Adolescent Health Care: the initial reproductive health visit","volume":"123","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jtha.2025.11.008_bib7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/AOG.0b013e318262e320","article-title":"Practice bulletin no. 128: diagnosis of abnormal uterine bleeding in reproductive-aged women","volume":"120","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jtha.2025.11.008_bib8","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1210\/endrev\/bnab011","article-title":"Hormone therapy in menopause: concepts, controversies, and approach to treatment","volume":"42","author":"Flores","year":"2021","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jtha.2025.11.008_bib9","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1055\/s-0031-1287662","article-title":"The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding","volume":"29","author":"Fraser","year":"2011","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.jtha.2025.11.008_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2217\/whe.15.85","article-title":"Outcome measures for heavy menstrual bleeding","volume":"12","author":"Quinn","year":"2016","journal-title":"Womens Health (Lond) Jan"},{"key":"10.1016\/j.jtha.2025.11.008_bib11","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1471-0528.1980.tb05013.x","article-title":"Relation between measured menstrual blood loss and patient's subjective assessment of loss, duration of bleeding, number of sanitary towels used, uterine weight and endometrial surface area","volume":"87","author":"Chimbira","year":"1980","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.jtha.2025.11.008_bib12","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1182\/hematology.2024000661","article-title":"Quantifying menorrhagia and overview of nonsurgical management of heavy menstrual bleeding","volume":"2024","author":"Wheeler","year":"2024","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jtha.2025.11.008_bib13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12905-020-0887-y","article-title":"Pictorial methods to assess heavy menstrual bleeding in research and clinical practice: a systematic literature review","volume":"20","author":"Magnay","year":"2020","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.jtha.2025.11.008_bib14","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1471-0528.1990.tb16249.x","article-title":"Assessment of menstrual blood loss using a pictorial chart","volume":"97","author":"Higham","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.jtha.2025.11.008_bib15","article-title":"Discussing menstrual health in family medicine","volume":"12","author":"Casola","year":"2024","journal-title":"Fam Med Community Health"},{"key":"10.1016\/j.jtha.2025.11.008_bib16","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jpag.2018.10.001","article-title":"Menstrual cycles: who cares? we all should","volume":"31","author":"Adams Hillard","year":"2018","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.jtha.2025.11.008_bib17","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood-2015-08-665927","article-title":"Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use","volume":"11","author":"Martinelli","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.11.008_bib18","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1182\/blood-2016-01-692053","article-title":"Less menorrhagia for women with VTE","volume":"127","author":"Schulman","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.11.008_bib19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/MBC.0000000000000800","article-title":"Rivaroxaban and the EINSTEIN clinical trial programme","volume":"30","author":"Cohen","year":"2019","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jtha.2025.11.008_bib20","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1182\/blood.2023021717","article-title":"Longitudinal profile of estrogen-related thrombotic biomarkers after cessation of combined hormonal contraceptives","volume":"143","author":"Hugon-Rodin","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.11.008_bib21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/bmj.302.6771.269","article-title":"Changes in haemostasis after stopping the combined contraceptive pill: implications for major surgery","volume":"302","author":"Robinson","year":"1991","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2025.11.008_bib22","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1097\/AOG.0000000000003072","article-title":"ACOG Practice Bulletin No. 206: use of hormonal contraception in women with coexisting medical conditions","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jtha.2025.11.008_bib23","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1001\/jama.293.19.2352","article-title":"Thrombophilia, clinical factors, and recurrent venous thrombotic events","volume":"293","author":"Christiansen","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2025.11.008_bib24","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.thromres.2020.05.008","article-title":"Estrogen and thrombosis: a bench to bedside review","volume":"192","author":"Abou-Ismail","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.11.008_bib25","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1182\/hematology.2024000591","article-title":"Estrogen, progestin, and beyond: thrombotic risk and contraceptive choices","volume":"2024","author":"Skeith","year":"2024","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jtha.2025.11.008_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12570","article-title":"Menstruation, anticoagulation, and contraception: VTE and uterine bleeding","volume":"5","author":"Samuelson Bannow","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.11.008_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100072","article-title":"How do anticoagulants impact menstrual bleeding and quality of life? The PERIOD study","volume":"7","author":"Patel","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.11.008_bib28","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1182\/blood.2022017101","article-title":"Incidence and impact of anticoagulation-associated abnormal menstrual bleeding in women after venous thromboembolism","volume":"140","author":"de Jong","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.11.008_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2017.05.001","article-title":"Abnormal uterine bleeding in women receiving direct oral anticoagulants for the treatment of venous thromboembolism","volume":"93\u201395","author":"Godin","year":"2017","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.jtha.2025.11.008_bib30","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1111\/jth.14226","article-title":"Less abnormal uterine bleeding with dabigatran than warfarin in women treated for acute venous thromboembolism","volume":"16","author":"Huisman","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.11.008_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102448","article-title":"Heavy menstrual bleeding on direct factor Xa inhibitors: the MEDEA randomized clinical trial","volume":"8","author":"Hamuly\u00e1k","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.11.008_bib32","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/1471-0528.15388","article-title":"Abnormal vaginal bleeding in women of reproductive age treated with edoxaban or warfarin for venous thromboembolism: a post hoc analysis of the Hokusai-VTE study","volume":"125","author":"Scheres","year":"2018","journal-title":"BJOG"},{"key":"10.1016\/j.jtha.2025.11.008_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12512","article-title":"Reproductive issues in women on direct oral anticoagulants","volume":"5","author":"Beyer-Westendorf","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.11.008_bib34","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1182\/blood-2017-07-797423","article-title":"How I treat heavy menstrual bleeding associated with anticoagulants","volume":"130","author":"Boonyawat","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.11.008_bib35","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1182\/hematology.2022000401","article-title":"Anticoagulant therapy for women: implications for menstruation, pregnancy, and lactation","volume":"2022","author":"DeLoughery","year":"2022","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jtha.2025.11.008_bib36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2217\/whe.15.100","article-title":"Medical management of heavy menstrual bleeding","volume":"12","author":"Maybin","year":"2016","journal-title":"Womens Health (Lond)"},{"key":"10.1016\/j.jtha.2025.11.008_bib37","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/AOG.0000000000004899","article-title":"General approaches to medical management of menstrual suppression: ACOG Clinical Consensus No. 3","volume":"140","year":"2022","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jtha.2025.11.008_bib38","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ijgo.2014.09.027","article-title":"Prevalence of heavy menstrual bleeding and experiences of affected women in a European patient survey","volume":"128","author":"Fraser","year":"2015","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jtha.2025.11.008_bib39","first-page":"26","article-title":"Iron deficiency in menstruating adult women: much more than anemia","volume":"1","author":"Fernandez-Jimenez","year":"2020","journal-title":"Womens Health Rep (New Rochelle)"},{"key":"10.1016\/j.jtha.2025.11.008_bib40","article-title":"Antifibrinolytics for heavy menstrual bleeding","volume":"4","author":"Bryant-Smith","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jtha.2025.11.008_bib41","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/rth2.12471","article-title":"Heavy menstrual bleeding on direct factor Xa inhibitors: rationale and design of the MEDEA study","volume":"5","author":"Hamuly\u00e1k","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.11.008_bib42","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence","volume":"188","author":"Baird","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jtha.2025.11.008_bib43","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/j.1365-2516.2010.02269.x","article-title":"The impact of menstrual disorders on quality of life in women with inherited bleeding disorders","volume":"16","author":"Kadir","year":"2010","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.11.008_bib44","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.contraception.2008.11.012","article-title":"Side effects from the copper IUD: do they decrease over time?","volume":"79","author":"Hubacher","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.jtha.2025.11.008_bib45","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/AOG.0000000000002706","article-title":"ACOG Practice Bulletin No. 196: thromboembolism in pregnancy","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jtha.2025.11.008_bib46","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1182\/bloodadvances.2018024802","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy","volume":"22","author":"Bates","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.11.008_bib47","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1111\/j.1538-7836.2007.02634.x","article-title":"Long-term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial","volume":"5","author":"Rodger","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.11.008_bib48","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11239-015-1309-0","article-title":"Guidance for the treatment and prevention of obstetric-associated venous thromboembolism","volume":"41","author":"Bates","year":"2016","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2025.11.008_bib49","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.jtha.2023.03.015","article-title":"Multidisciplinary care of the pregnant patient with or at risk for venous thromboembolism: a recommended toolkit from the Foundation for Women and Girls with Blood Disorders Thrombosis Subcommittee","volume":"21","author":"Samuelson Bannow","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.11.008_bib50","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/bmj.39555.441944.BE","article-title":"Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis","volume":"336","author":"Canonico","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2025.11.008_bib51","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/CIRCULATIONAHA.106.642280","article-title":"Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study","volume":"115","author":"Canonico","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2025.11.008_bib52","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(03)14066-4","article-title":"Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk","volume":"362","author":"Scarabin","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2025.11.008_bib53","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.thromres.2018.06.014","article-title":"Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: a systematic review and meta-analysis","volume":"168","author":"Rovinski","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.11.008_bib54","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.thromres.2023.09.002","article-title":"Hemostatic considerations for gender affirming care","volume":"230","author":"Garland","year":"2023","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.11.008_bib55","article-title":"Risk of venous thromboembolism in the transgender population on hormone therapy: a systematic review","volume":"164","author":"Franco-Moreno","year":"2025","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.jtha.2025.11.008_bib56","first-page":"516","article-title":"Hematologic concerns in transgender patients","volume":"20","author":"DeLoughery","year":"2022","journal-title":"Clin Adv Hematol Oncol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625008475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625008475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T07:20:52Z","timestamp":1778224852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783625008475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1538783625008475"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.11.008","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticoagulation stewardship from menstruation to menopause: a toolkit for clinical management","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}